Patricia L Painter1, Adhish Agarwal2,3, Micah Drummond4. 1. Department of Physical Therapy, University of Utah, Salt Lake City, UT, USA Trish.painter@hsc.utah.edu. 2. Division of Nephrology and Hypertension, University of Utah, Salt Lake City, UT, USA. 3. Nephrology of Northern Utah, Ogden, UT, USA. 4. Department of Physical Therapy, University of Utah, Salt Lake City, UT, USA.
Abstract
BACKGROUND: Physical functioning (PF) and physical activity (PA) are low in patients treated with maintenance hemodialysis (MHD). Little information exists on this topic in patients treated with peritoneal dialysis (PD). The objective of this study was to compare PF and PA in patients with Stage-5 chronic kidney disease (CKD) treated with PD and in-center MHD. METHODS: Physical functioning was measured in 45 prevalent PD patients using standard physical performance measures that include gait speed, chair stand, standing balance, 6-minute-walk, incremental shuttle walk and self-reported PF using the short form (SF)-36 questionnaire. Physical activity was determined from self-report and using the Community Healthy Activities Model Program for Seniors (CHAMPS) questionnaire. Scores for the short physical performance battery (SPPB) were calculated. In-center MHD patients were matched by age, gender, and diabetes status to the PD patients. RESULTS: Unadjusted comparisons showed significantly higher 6-minute-walk distance, shuttle-walk distance and hand-grip in the PD patients. Adjustment in multiple regression analysis resulted in only gait speed being significantly different between the groups. All test results in both groups were lower than reference values for age and gender in the general population, and were at the levels indicating impairment. Physical activity was not different between the 2 groups (average age 49 yrs), and both groups had weekly caloric expenditure from all exercise and from moderate-intensity exercise that was similar to older (> 70 yrs) community-dwelling adults. Adjusted association indicated that PA was significantly associated with shuttle-walk distance. CONCLUSIONS: Physical functioning and PA measures were low in both PD and MHD groups. Interventions to improve PA and PF should be strongly considered for both PD and MHD patients.
BACKGROUND: Physical functioning (PF) and physical activity (PA) are low in patients treated with maintenance hemodialysis (MHD). Little information exists on this topic in patients treated with peritoneal dialysis (PD). The objective of this study was to compare PF and PA in patients with Stage-5 chronic kidney disease (CKD) treated with PD and in-center MHD. METHODS: Physical functioning was measured in 45 prevalent PDpatients using standard physical performance measures that include gait speed, chair stand, standing balance, 6-minute-walk, incremental shuttle walk and self-reported PF using the short form (SF)-36 questionnaire. Physical activity was determined from self-report and using the Community Healthy Activities Model Program for Seniors (CHAMPS) questionnaire. Scores for the short physical performance battery (SPPB) were calculated. In-center MHD patients were matched by age, gender, and diabetes status to the PDpatients. RESULTS: Unadjusted comparisons showed significantly higher 6-minute-walk distance, shuttle-walk distance and hand-grip in the PDpatients. Adjustment in multiple regression analysis resulted in only gait speed being significantly different between the groups. All test results in both groups were lower than reference values for age and gender in the general population, and were at the levels indicating impairment. Physical activity was not different between the 2 groups (average age 49 yrs), and both groups had weekly caloric expenditure from all exercise and from moderate-intensity exercise that was similar to older (> 70 yrs) community-dwelling adults. Adjusted association indicated that PA was significantly associated with shuttle-walk distance. CONCLUSIONS: Physical functioning and PA measures were low in both PD and MHD groups. Interventions to improve PA and PF should be strongly considered for both PD and MHD patients.
Authors: Amelie Bernier-Jean; Nadim A Beruni; Nicola P Bondonno; Gabrielle Williams; Armando Teixeira-Pinto; Jonathan C Craig; Germaine Wong Journal: Cochrane Database Syst Rev Date: 2022-01-12
Authors: Jeonghwan Lee; Yong Chul Kim; Soie Kwon; Lilin Li; Sohee Oh; Do Hyoung Kim; Jung Nam An; Jang-Hee Cho; Dong Ki Kim; Yong-Lim Kim; Yun Kyu Oh; Chun Soo Lim; Yon Su Kim; Jung Pyo Lee Journal: Kidney Res Clin Pract Date: 2020-12-31
Authors: Marthley J C Costa; Frederico C B Cavalcanti; Shirley Dias Bezerra; José Candido de Araújo Filho; Juliana Fernandes; Patrícia E M Marinho Journal: J Bras Nefrol Date: 2022 Apr-Jun
Authors: Paul N Bennett; Wael F Hussein; Kimberly Matthews; Mike West; Erick Smith; Marc Reiterman; Grace Alagadan; Bryan Shragge; Jignesh Patel; Brigitte M Schiller Journal: Kidney Med Date: 2020-03-17